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CHAPTER I 
INTRODUCTION 
INTRODUCTION 
Metal based chemotherapeutic agents are receiving ever-increasing 
recognition as overuse of drugs has resulted in large number of bacterial or 
viral strains which are resistant, thereby are inactivated [1]. Currently, the most 
common antibiotics are ^lactam and quinolone containing compounds, which 
includes pencillin, cephalosporin, norfloxacin, ciprofloxacin, sparfloxacin etc. 
The well- known cisplatin which is being employed for the treatment of 
testicular cancer has also acquired resistance and led to treatment failures [2]. 
The prevalence of bacterial resistance or acquired resistance is quickly making 
the currently-used drugs ineffective. This has spurred research in the 
development of new potential inhibitors as metal based drugs which are 
targeted at the specific molecular level [3]. Since it is understood that bacterial 
strains utilize a number of diverse strategies to make themselves resistant such 
as hydrolysis of the drug, binding and transport of the compound out of the 
cell, modifying cellular components and pathways, therapies to address these 
resistant strains should also be diverse. 
Metal ions play a key role in large number of important biological 
processes, structure-function relationship are important as each metal ion has a 
specific role in different biological environments [4]. The use of metals like Fe 
and Cu in medicines can be traced to ancient Greeks and Hebrews. Metals and 
their complexes have been used in the treatment of various ailements and 
diseases. Selection of metal ions offers possibility for the discovery of metallo 
drug with novel mechanism of action [5]. Among metal ions commonly used 
over centuries were Hg^^ for the treatment of syphilis, Mg^^ for intestinal 
disorders and Fe^^ for anemia. With the advent of cisplatin-well known cancer 
drug, metal based pharmaceuticals have reached hilarious heights and have set 
a footmark in important area of inorganic pharmaceuticals. Metal-based 
pharmaceuticals are receiving ever-increasing recognition for their roles in 
inhibiting growth of cancer cells and destroying other micro-organisms. 
Metal ions also play a key role in the action of some synthetic and 
natural antibiotics and are involved in specific interaction of these antibiotics 
with proteins, membranes, nucleic acids and other biomolecules [6]. Removal 
of metal ions thus results in deactivation or change in structure of these 
antibiotics, such as bacitracin, bleomycine (BLM), streptonigrin (SN). 
albomycin. However, in other cases, the binding of metal ions to the antibiotic 
molecules may engender profound chemical and biochemical consequences, 
which may not significantly affect the structure of the drug such as 
tetracyclines, aureolic acid and quinolone. These antibiotics have been named 
as "metalloantibiotics" [7]. Metallo antibiotics are capable of specific protein -
DNA interaction. DNA is a target for therapeutic treatment of disorders and 
diseases such as cancer, malignant lymphoma, Alzheimer's AD and molecular 
drug design aim to combat diseases by targeting specific gene expression and 
sequence selective binding of drugs [8]. Several clinically used anticancer 
antibiotics such as bleomycin (BLM) and actinomycine (AC) are DNA-binding 
and cleaving agents. The investigation of the interaction of DNA in the 
synthetic metal complex derived from antibiotics can provide clues for rational 
design of DNA-specific future drugs. The structural relationship the mode of 
action and toxicity of these drugs can provide information to design the more 
effective, less toxic drugs for future therapeutic treatments. The investigation of 
the interaction of DNA with metal complexes (derived from antibiotics) would 
provide clues for rational design of DNA-specific drugs. 
Numerous methods, including uv-vis. spectroscopy, fluorescence 
spectroscopy, Raman spectroscopy and X-ray have been used to study these 
interactions [9]. Electrochemical methods have been used to study the 
interactions of these molecules with DNA in solutions. This technique has been 
used for the determination of complexes of pharmaceutical interest [10], 
because of its sensitivity and short response time, electroanalytics can be 
applied to dynamic systems to determine physicochemical, thermodynamic and 
kinetic parameters [11]. Generally, the analysis can be performed with prior 
separation (as opposed to uv., HPLC) of the active form and could be used to 
study insitu physiochemical process involved, when a drug or dosage form is 
in the presence of a dissolution medium. The practical application of 
electrochemistry includes the determination of electrode oxidation mechanism. 
Due to the known resemblance between electrochemical and biological 
reactions, it can be assumed that the redox mechanism taking place at the 
electrode and in the body share similar principles [12]. 
Cyclic voltammetry (CV) is the most effective and versatile 
electroanalytical technique available for the mechanistic study of redox 
systems. The obtained results from the redox properties of drugs and 
biomolecules might have profound effects on our understanding of their invivo 
redox behavior and pharmaceutical activity. Some metabolites can be 
difTerentiated from the parent compounds since the metabolism often proceeds 
through the addition or the modification of a constituent and this will give an 
additional wave or to a shift of the redox potential [13]. The application of 
electrochemical methods to the study of metallointeraction and coordination of 
metal ions and chelates to DNA provide a usefiil complement to the previously 
used methods of investigations such as uv-visible spectroscopy. Small 
molecules which sometimes give weak absorption bands or overlap of 
electronic transitions occurs after interaction with DNA can potentially be 
studied through voltammetric techniques. Electrochemistry has been applied to 
probe both intercalation and electron transfer in DNA and was particularly 
usefiil improving metal-DNA interaction by studying redox mechanism 
involved in equous medium. 
Equilibrium constant (K) for the interaction of the metal complexes with 
DNA can be obtained from shift in peak potential, and the number of base pair 
sites involved in binding via intercalation, electrostatic or hydrophobic 
interaction can be obtained from the dependence of current passed during 
oxidation or reduction of the bound species on the amount of added DNA [14]. 
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A number of studies have explored electrochemistry of DNA through 
redox reactions of purine and pyrimidine bases. Several anthracycline 
antibiotics, which bind to DNA via intercalation and electrostatic with sugar-
phosphate backbone have been studied electrochemically [15]. The interaction 
between rutin or the inclusion complex of rutin-p-cyclodextrin and DNA were 
investigated by cyclic voltammetry. The results revealed that the benzopyranic-
4-one plane of rutin mainly intercalated into DNA in the absence of P-
cyclodextrin, while the catecholic portion of rutin was located in the double 
helix of DNA in the presence of P-cyclodextrin [16]. Similarly, some 
biologically important indolylthiohydantoin derivative were investigated 
electroanalytically by voltammetric determinations. The voltammograms of 
these compounds show that the oxidation steps occur for all the compounds on 
the nitrogen atom in the indole ring, which is electroactive in both acidic and 
basic media, leading finally to hydroxylation of the benzene ring [17]. 
Figure 1: Structure of Indolythiohydantan derivative 
Flouroquinolones, a new group of synthetic analogue of naldixic acid 
are broad spectrum antibacterial agents effective against many gram positive 
and gram negative bacteria [18]. Sparfloxacin, a new addition to the fourth 
generation quinolones is promising against cuttaneous allergy, tuberculosis and 
urinary tract infection [19]. Sparfloxacin is an advanced aminoflouroquinolone 
which exerts its antibacterial activity by inhibiting the supercoilng activity of 
bacterial DNA gyrase (or topoisomerase), which is an enzyme essential for 
DNA replication [20]. 
NH2 O 
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Figure 2: Structure of Sparfloxacin 
Interaction of ciprofloxacin incorporated inside silica nanobubbles with 
lanthanides ions especially Eu" ,^ Tb"^ has been studied which exhibit unique 
fluorescent properties. Electrochemical properties of ciprofloxacin @ SiOi 
were studied by cyclic voltammetry. Free ciprofloxacin shows two irreversibh 
cathodic reduction peaks at -0.75 and -1.18V, which can be attributed to the 
reduction of piperzinyl and pyridone moieties respectively [21]. 
A new boroderivative of ciprofloxacin and its Cu" complexes have been 
synthesized and characterised by various physicochemical methods. The 
interaction of ligand and its Cu" complex have been monitored 
spectrophotometrically and by cyclic voltammetrically. The k^ bs value have 
been calculated under pseudo first order conditions and it has been observed 
that the Cu" complex is a more efficient DNA inhibitor than the free borate 
ligand. The redox behavior of the Cu" complex in the presence and absence of 
CTDNA in aqueous solutions have been investigated by cyclic voltammetn. 
[22]. 
0 X KfeOu/ \MeOH ^ 0 . ( N O , ) 
Figure 3: Structure ofcopper(II) complex C36H44N7O11F2B Cu 
Reaction of transition metal complexes of 14-membered hexa azo 
macrocycle with DNA has been studied by cyclic voltammetry methods [23]. 
The synthesis and characterization of new metal complexes with quinolone 
antibacterial agents are of great importance for understanding the drug-metal 
ion interaction and for their potential pharmacological use. Reaction of 
quinolone ciprofloxacin and its Co" complex in aqueous medium was studied 
by uv-visible spectroscopy in the pH range 5-10 [24]. Flouroquinolone (FQs) 
lemofloxacin (LOM) and enoxacin (ENX) binding to CTDNA [25] have been 
investigated at neutral pH through several spectroscopic techniques (uv-vis. 
induced circular dichromism, Fluoresence studies etc.). 
Present work 
Fluoroquinolones (FQs), ciprofloxacin, lemofloxacin, Norfloxacin 
sparfloxacin, are the broad spectrum antibacterial agents effective against 
various infectious disorders. The co-ordination chemistry of these drugs with 
metal ions of biological and pharmaceutical importance is of considerable 
interest. Serving as attractive scaffold for drug design and are conforing drug 
like characteristics into numerous structural motifs. They have potential donor 
atoms available for metal binding through oxygen of carboxylic group, oxygen 
of pyridone moiety and nitrogen of piperazine ring. Such binding are likely to 
leave some potential donor atoms free and these free donor atoms enhance the 
biological activity. New metal based Fluoroquionolones were prepared in a 
simple and an efficient manner to combat diseases like cancer and HIV as 
literature reveal, metal-based fluoroquinolones exert more pathogenic activity 
against various diseases. 
To rationalize these findings, we have synthesized a novel ligand from 
sparfloxacin (N-Methylene Succinimide Sparfloxacin) (L), and subsequently its 
metal complexes of the type [C24H28F2N6O9M"] (M=Co", N,", Cu") were 
synthesized and characterised by various physicochemical methods. On the 
basis of analytical and spectral data, squar planer geometry has been proposed 
for the metal complexes. The redox behavior of metal complexes were 
recorded at different pH's. Competitive mode of binding of the ligand and its 
metal complex with CTDNA was studied spectrophotometrically and by cyclic 
voitammetry. The binding constant Kb for DNA bound ligand and metal 
complexes have been calculated. 
CHAPTER II 
EXPERIMENTAL 
EXPERIMENTAL METHODS 
The following techniques were employed to characterize the complexes 
1. Infrared spectroscopy 
2. Ultra-violet and visible spectroscopy 
3. Nuclear magnetic resonance spectroscopy 
4. Electron paramagnetic resonance spectroscopy 
5. Cyclic voltammetry 
6. Kinetic studies 
Infrared spectroscopy 
The infrared spectroscopy is a usefiil technique to characterize a 
compound. It results from transition between vibrational and rotational energy 
levels. I.r. region of the electromagnetic spectrum covers a wide range of 
wavelength from 200 to 4000 cm'. It has been found that in i.r. absorption, 
some of the vibrational frequencies are associated with specific groups of 
atoms and are the same irrespective of the molecules in which this group is 
present. These are called characteristic frequencies [26] and their constancy 
results from the constancy of bond force constants from molecule to molecule. 
The important observation that the i.r. spectrum of a complex molecule consists 
of characteristic group frequencies which makes i.r. spectroscopy, a unique and 
powerfiil tool in structural analysis. 
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Ultraviolet and visible spectroscopy 
When a molecule absorbs radiation, its energy is increased. This 
increased energy is equal to the energy of the photon expressed by the relation 
E = hv 
E =hc/X 
where h is Planck's constant, v is the frequency, X is the wavelength of the 
radiation and c is the velocity of light. Most of the compounds absorb light in 
the spectral region between 200 and 1000 nm. These transitions correspond to 
the excitation of electrons of the molecules from ground state to higher 
electronic states. In a transition metal, all the five 'd' orbitals viz. dxy, d^ ,^ d^ z, 
dz and dx .y are degenerate. However, in coordination compounds due to the 
presence of ligands, this degeneracy is destroyed and d orbital split into two 
groups t2g (dxy, dyz and dxz) and Cg (d^ ^ and dx^ .y^ ) in an octahedral complex and t 
and e in a tetrahedral complex. The set of tig orbitals goes below the original 
level of degenerate orbitals in octahedral complexes and the case is reversed in 
tetrahedral complexes (Figure 4). At energy higher than the ligand-field 
absorption bands, we commonly observe one or more very intense bands that 
y^'j '(i-'-,-' , ,r X 
lODq 
Fretion 
Hypodieticaf ion 
in a spherically 
jynunetric field 
dsy <l,, J , -
OctahediaJ 
field 
rir 
bDq 
Figure 4. Splitting of the d energy levels in an octahedral complex. 
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Figure 4(b). Ligand-field splitting of tetrahedral complex. 
go off scale unless log e is plotted. These normally are charge transfer bands, 
corresponding to electron transfer processes that might be ligand —• metal 
(L—•M) or metal —• ligand (M—•L). M—•L transitions occur for metal-ion 
complexes that have filled, or nearly filled, t2g orbitals with ligands that have 
low-lying empty orbitals. These empty orbitals are ligand TI* orbitals in 
complexes such as those of pyridine, bipyridine, 1,10-phenanthroline, CN", CO 
and NO. (Figure 5) shows overlap of a tig metal orbital and %* of CO. 
Ni—CaEQJ Ni«=C = 0 
Valence bond represenwion 
(o) 
n' 
C s O 
(t) 
Molecular orbital 
represeniation 
Figure 5. Metal-carbon double bonding. 
The L — -^M charge-transfer (C-T) spectra have been studied more thoroughly. 
The intense bands are for Laporte-allowed transitions commonly of the 
(ligand)/?—• J (metal) type. The ionization energy for the ligand (or its ease of 
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oxidation) as well as the oxidation state and electron configuration of the metal 
(or its ease of reduction) determine the energy of the transition. No net 
oxidation-reduction usually occurs, because of the short lifetime of the excited 
state [27]. 
Nuclear magnetic resonance spectroscopy 
The nuclei of certain isotopes possess a mechanical spin or angular 
momentum. The n.m.r. spectroscopy is concerned with nuclei having spin 
quantum number I = 1/2, example of which include ' H , '^C, " 'P and '^F. 
For a nucleus with I = 1/2, there are two values for the nuclear spin 
angular momentum quantum number mr= ±1/2 which are degenerate in the 
absence of a magnetic field. However, in the presence of the magnetic field, this 
degeneracy is destroyed such that the positive value of mi corresponds to the 
lower energy state and negative value to higher energy state separated by AE. 
In an n.m.r. experiment, one applies strong homogeneous magnetic field 
causing the nuclei to precis. Radiation of energy comparable to AE is then 
imposed with radio frequency transmitter is equal to precision or Larmor 
frequency and the two are said to be in resonance. The energy can be 
transferred fi-om the source to the sample. The n. m. r. signal is obtained when 
a nucleus is excited from low energy to high energy state. 
Electron spin resonance spectroscopy 
E.P.R spectroscopy [28] is the branch of absorption spectroscopy in 
which radiation having frequency in the microwave region is absorbed by 
paramagnetic energy levels of electrons with unpaired spins. The magnetic 
energy splitting is done by applying a static magnetic field. For an electron of 
spin S = 1/2, the spin angular momentum quantum number will have values of 
ms = +1/2. In absence of magnetic field, the two values of ms i.e. +1/2 and -
1/2 will give rise to a doubly degenerate spin energy state. If a magnetic field is 
applied, this degeneracy is lifted and leads to the non-degenerate energy levels. 
The low energy level will have the spin magnetic moment aligned with the 
field and correspond to the quantum number mj = -1/2. On the other hand, the 
high energy state will have the spin magnetic moment opposed to the field and 
correspond to the quantum number ms = +1/2. 
Cyclic voltammetry 
Cyclic voltammetry involves the measurement of current-voltage curves 
under diffusion controlled, mass transfer conditions at a stationary electrode, 
utilizing symmetrical triangular scan rates ranging from a few millivolts per 
second to hundred volts per second. The triangle returns at the same speed and 
permits the display of a complete polarogram with cathodic (reduction) and 
anodic (oxidation) waveforms one above the other. Two seconds or less is 
required to record a complete polarogram [29]. 
Consider the reaction 
O + ne • R (i) 
Assuming semi-infinite linear diffusion and a solution containing 
initially only species O. With the electron held at a potential Ej where no 
electrode reactions occur. The potential is swept linearly at v v/sec so that the 
potential at any time is 
E(t) = Ei-vt 
or Epeak = Ei/2-0.0285 
The rate of electron transfer is so rapid at the electrode surface that 
species O and R immediately adjust to the ratio according to the Nemst 
equation, which is as follows, 
C„(0,t) = Co* - [nFA(7tDo)''']' i(7c)(t-T)-''' dx (ii) 
i = nFACo*(7tDoa)''^  X (a t) (iii) 
Redox (electron-transfer) reactions of metal complexes can be 
investigated by cyclic voltammograms. An electrode is immersed in a solution 
of the complex and voltage is swept while current flow is monitored. No 
current flows until oxidation or reduction occurs. After the voltage is swept 
over a set range in one direction, the direction is reversed and swept back to the 
original potential. The cycle may be repeated as often as desired. (Figure 7) 
shows the cyclic voltammograms (CV) for a reversible one-electron redox 
reaction such as, 
CpFe(CO)LMe • CpFe(CO)LMe^ + e" 
Sweeping the potential in an increasing direction oxidize the complex as 
the anodic current ia flows; reversible reduction of CpFe(CO)LMe^ generates 
cathodic current ic on the reverse sweep. The magnitude of the current is 
proportional to the concentration of the species being oxidized or reduced. 
The measured parameters of interest on these cyclic voltammograms are 
ipa/ipc the ratio of peak currents and Epa - Epc the separation of peak potentials. 
For a Nernstian wave with stable product, the ratio ipa/ipc = 1 regardless of scan 
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rate, Ex and diffusion coefficient, when ipa is measured from the decaying 
current as a base line. The difference between Epa and Epc (AEp) is a useful 
diagnostic test of a Nemstian reaction. Although AEp is slightly a fiinction of 
Ex, it is always close to 2.3RT/ nF. 
Figure 6. (a) Cyclic potential sweep (b) Resulting cyclic voltammogrant 
The technique yields information about reaction reversibilities and also 
offers a rapid means of analysis for suitable systems. The method is 
particularly valuable to study metallo-intercalation and interaction of metal 
ions to DNA as it provides a usefiil compliment to other methods of 
investigation, such as UV/Vis spectroscopy. Cyclic voltammetric 
measurements were accomplished with CH instrument electrochemical 
analyzer. Supporting electrolyte for the experiments was 0.4 M KNO3/O.4 M n-
BU4NCIO4 A three electrode configuration was used, comprising of a platinum 
disk as working electrode, platinum wire counter electrode and Ag/AgCl as 
reference electrode. All solutions were deoxygenated via. purging with N2 at 
room temperature. Azad l-ibf 
- ^ Z^"t: 
^ \oc. No .:::;. ' 
Kinetic studies 
In a closed constant volume system, the rate of a chemical reaction is 
defined as the rate of change with time of the concentration of any of the 
reactants and products. The concentration can be expressed in any units of 
quantity per unit volume e.g. moles per liter, moles per cubic centimeter. The 
rate will be defined as positive quantity regardless of the component whose 
concentration change is measured. 
Consider the general chemical reaction 
aA + bB • cC + dD 
The rate can be expressed as 
-dA , rdB. , .dC. or dP 
dt dt dt dt 
where A, B, C and D designate the concentration in arbitrary units. 
The rate of a chemical reaction is not measured directly instead the 
concentration of one of the reactants or products is determined as a function of 
time. A common procedure for determining the reaction order is to compare the 
experimental results with integrated rate equations for reactions of different 
orders. For a first order rate equation, integrating by separate variables using 
integration limits such that at t = 0, c = CQ and at t = t, c = c [30]. 
-dc/dt = kc 
or ln(co/c) = kt 
If the reaction is first order, a plot of In c or log c versus time should 
give a straight line with a slope of -k or -k/2.303 respectively. The dependent 
i / 
variable chosen is the decrease in concentration of reactant. If this variable is 
designated as x and Co is the initial concentration, 
dx/dt = k(co-x) 
In Co / (co-x) = kt 
If however, the conditions for a given reaction are such that one or more 
of concentration factors are constant or nearly constant during a reaction, these 
factors are included in the constant k. In this case, the reaction is said to be of 
pseudo-nth order or kinetically nth order where n is the sum of the exponents 
of those concentration factors which alter the reaction [31]. 
u 
DO 
o 
This situation is true for catalytic reactions where the concentration of 
catalysts remains constant throughout the reaction, if one reactant is in large 
excess over another so that during the reaction there is only a small percentage 
change in the concentration of the former reactant. 
Another set of experiments involving interaction of the complex with 
calf thymus DNA were conducted in buffer (9.2 pH), doubly distilled water and 
tris-HCl buffer (7.5 pH), respectively. The intrinsic binding constant, Kb of the 
complex to calf thymus DNA was determined from Eq (3) [32] through a plot 
of [DNA]/ E2-8f versus [DNA]. 
[DNA] = [DNA] ^ _ J (3) 
8a-£f Eb-Ef Kb(eb-£f) 
Where [DNA] represents the concentration of DNA. Eg, Ef and £b are 
respectively the apparent extinction coefficient (A<,bs/[M]), the extinction 
coefficient for free metal (M) complex and the extinction coefficient for free 
metal (M) complex in the fully bound form. In plots of [DNA]/ Ea-Ef versus 
[DNA], Kb is given by the ratio of slope to intercept. 
Calf thymus DNA was obtained from Sigma. The stock solution of calf 
thymus DNA was prepared by dissolving it in 10 mM tris(hydroxymethyl) 
aminomethane hydrochloride (tris-HCl) buffer at pH 7.5 and dialyzing 
exhaustively against the same buffer for 48 h. The solution gave a ratio of 
» 1 . 8 at A26o/A2805 indicating that calf thymus DNA was free from protein [33]. 
The concentration of calf thymus DNA was determined spectrophotometrically 
by monitoring the u.v. absorbance at 260 nm using I260 = 6600 cm". The 
stock solution was stored at -20 ''C. 
Materials 
The pharmaceutical grade pure Sparfloxacin (Rhyddur Pharmaceutical 
Ltd), Succinimide (Lancaster) and Formaldehyde (E. Merck) were used as 
received. The Calf thymus DNA (CTDNA) was purchased from Sigma. All 
other reagents were used of pharmaceutical grade. The double distilled water 
was used throughout. 
Physical measurements 
Microanalysis of the complexes were carried out on a Carlo Erba 
analyser model 1108. Molar conductance was measured at room temperature 
on a Digisun electronics conductivity bridge. Infrared spectra were recorded on 
a Shimadzu 8201,Pc spectrophotometer in Nujol mull. The electronic spectra 
were recorded on a USB Ocean optics 2000 spectrometer. ' H , '^C n.m.r and 2D 
cosy n.m.r spectra were recorded on a Bruker DRX-300 spectrometer. The e.p.r 
spectrum of copper complex was run on a Varian El 12 spectrometer at X-band 
frequency (9.1GHZ) at liquid nitrogen temperature (LNT). Cyclic voltammetric 
(CV) measurements were carried out on a CH instrument electrochemical 
analyzer. All voltammetric experiments were performed in single 
compartmental cell at 25°C with H2O/DMSO (95:5) and 0.4 M KNO3 as a 
supporting electrolyte. A three electrode configuration was used, comprised of 
a Ft micro cylinder as working electrode. Ft wire as auxiliary electrode and an 
Ag/AgCl electrode as a reference electrode. All the experiments involving 
interaction of the complex with CTDNA were performed in aerated buffer 
(0.01M,pH 7.2). The CTDNA was dissolved in 0.01 M tris-HCl buffer and was 
dialyzed against the same buffer overnight. Solution cf DNA gave a ratio of uv 
absorbance at 260 and 280 nm, A260/A280 -1-9 indicating that the DNA was 
sufficiently free of protein. DNA concentration per nucleotide was determined 
by absorption spectroscopy using the molar absorption coefficient 6600 dm' 
mol"' cm"' at 260 nm [34]. 
20 
Synthesis of ligand (L){N-Methylene succinimide Sparfloxacin] 
(C24H27F2N5O5) 
Sparfloxacin (0.392g,lnimol) in ethanol (50cm^), succinimide 
(O.IOOg,lmmoI) and formaldehyde (0.73g,lmmol) were mixed in a 1:1:1 molar 
ratio. The resulting yellow solution obtained was refluxed in presence of few 
drops of H2SO4 for ca 20 hours. The light yellow colored precipitate obtained 
was filtered, washed with Et20 and dried in vacuo. Scheme 1. 
Synthesis of metal complexes[C24H28F2N609M"l(M"= Co", Ni" and Cu") 
Solution of ligand (L) (0.50 Ig, Immol) in DMF (25 cm') and hydrated 
copper nitrate [Cu(N03)2] (0.24Ig, Immol) were mixed in 1:1 molar ratio. The 
resulting mixture was refluxed for ca 5-8 hours. The volume of the refluxed 
solution was reduced to one fourth over rotatory evaporator and then allowed to 
stand overnight at room temperature. The green amorphous powder obtained 
was filtered, washed with Et20 and dried in vacuo. The same procedure were 
employed for the synthesis of Co" and Ni " complexes. Scheme 2. 
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Metallated complex M = Co {II), Ni (II), Cu (II). 
Scheme 2 
CHAPTER HI 
RESULTS AND DISCUSSION 
RESULTS AND DISCUSSION 
The analytical data for the sparfloxacin, the ligand and its metal 
complexes are listed in Table 1. The metal complexes are air stable, non 
hygroscopic and are soluble in DMSO/DMF but insoluble in non- polar organic 
solvents. 
I.r. spectra 
The important i.r. bands of pure sparfloxacin, the ligand [C24H27F2N5O5] 
(L) and its metal complexes were compared to study the binding mode of the 
ligand with metal ions (Table 2). The i.r. spectrum of pure sparfloxacin shows 
two characteristic bands at 1650-1720 cm'', 3100 cm'' and 3300 cm' due to 
carboxylic group (-COOH), (-NH2) and (-NH) stretching vibrations 
respectively [35,36]. Most of the bands appearing at 1434cm'(C-N ring 
stretching), 1025 cm'' (C-F stretching), 3100 cm' (NH2 stretching) and 1720 
cm'' (C=0 stretching) remain unaltered in the ligand. However, characteristic 
band at 3300 cm'' related to N-H stretching, disappears after the substitution 
reaction. The emergence of a new bands at 2276-2375 cm' corresponding to 
CH2 group indicate that N-Methylene succinimide gets attached to nitrogen (N-
4) of piperzine ring via CH2 bridging. The i.r spectra of the metal complexes 
are also quite shnilar due to the mvolvement of the carboxylate group in 
coordination with metal ions. Upon complexation of the ligand with metal ions 
[M = Co", Ni" and Cu"] the band at 1650-1720 cm' for carboxylate group 
(-COO) gets slightly shifted to lower wavenumber, clearly indicating that 
complexation of the metal ion occurs via the carboxylate group of the ligand 
[37]. The presence of new bands at 1130 cm'', 830-850 cm"' and 517-526 cm' 
are attributed to u(M-H20), u(M-N03) and i)(M-0) respectively [38]. The peak 
due to \)(M-H20) overlapped with u (-NH2) and appears at 3400 cm"'. 
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N.m.r Studies 
The *H n.m.r spectrum of the hgand [C24H27F2N5O5] (L) recorded ai 300 
MHz at room temperature reveals a sharp peak at 7.5-8.5 pom for aromatic 
protons, a singlet at 10-11.5 ppm due to carboxylic proton and a singlet at 3.8-
4.0 due to NH2 protons [39]. The formation of the ligand is authenticated by the 
absence of signal at 5.99 ppm for N-H proton of piperazine [40] and 
appearance of new singlet at 3.18 ppm for CH2 protons (N-CH2-N) bridging 
between succinimide and sparfloxacin [41] (Table 3). The '"C n.m.r data is in 
good agreement with the ' H n.m.r data of the ligand confirming the formation 
of ligand. The well resolved '"C NMR spectrum of the ligand gives prominent 
peaks at 178, 160, 150, 127, 52 ppm assigned to COO, C=0, C-F, Ar-C, N-C-
C-N groups respectively (Table 4). 
1 jk W ^*i^»^ii»WWW»WW*< /LJL-,»4AA^ 
13 Figure 8. "C-nmr spectrum of ligand IC24H27F2N505]. 
Substitution and complexation of the ligand with metal ions is further 
authenticated by 'H.n.m.r and 2D cosy n.m.r data (Table 5). The n.m.r spectra 
of ligand and its metal complex [C24H2gF2N609Ni"] are quite similar indicating 
that co-ordination to the metal ion does not show any remarkable change in the 
conformation of the ligand molecule except the absence of proton signal of 
carboxylic group. These n.m.r spectral results indicate that complexation takes 
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place via deprotonation of carboxylic proton. 2D cosy n.m.r spectrum of the Ni 
complex is also in good agreement with the ' H n.m.r data depicted in (Figure 9). 
Thus these spectral results are consistent with the proposed structure of metal 
complexes depicted in scheme 2. 
V 
Figure 9. 'H.n.nLr. spectrum of [C24ii2ftF2^609Ni^^] 
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Figure 10. 2D Cosy n.nur. spectrum of complex [C24H28F2N609Ni"] 
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Electronic absorption Spectra 
Electronic spectra of the complexes [C24H28F2N6O9M"] were recorded 
in DMSO at room temperature. The solution spectrum of copper complex 
[C24H2gF2N609Cu"] exhibits two sharp bands in the range of 300-380 nm 
(33,330-26,315 cm') which are attributed to intraligand charge transfer bands 
[42]. The prominent broad unresolved band in the range of 550-700 nm 
(18,181-14,285 cm"') is assigned to the spin allowed ^Big-^^A|g transitions of 
Cu " ion in an environment close to square planar [43]. Both square planer and 
rhombic geometries exhibit d-d absorption bands in same region, therefore, it is 
difficult to distinguish these absorption bands. Most of the copper complexes 
exhibit a band at 17,705 cm'' characteristic of square planer environment with 
CUNO3 coordination sphere [44]. The Ni " complex has a diamagnetic behavior 
and its electronic spectrum shows a shoulder at 440 nm (22,727 cm"') ascribed 
to 'A|g—»'Big transitions supporting the square planer geometry around Ni " ion 
[45]. 
E.p.r spectrum 
The solid state x-band (w9.1GHz) e.p.r spectrum of the complex 
[C24H28F2N6O9CU"], were recorded at liquid nitrogen temperature(LNT) (77k). 
The g|| and gi values were computed from the spectrum using tetracynoeth-
ylene (TCNE) as 'g' marker and found to be g|r2.37 gi=2.086 and gav=2.180. 
gav value was obtained according to the equation gav^=(g||"+2gi^)/3. The 
existence of g||>gi suggest that dx2.y2 is the ground state with the d^  (Cu^") 
configuration i.e.(eg) '', (aig) ^ (b2g) "^  (big) ' which commensurate with the 
square-planar environment around the Cu" ion present in the outer site of the 
ligand [46]. The g values are also related to the axial symmetry parameter, G 
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by the expression G =(g(|-2)/(gi-2) [24]. If G<4, considerable exchange 
interaction occurs, whereas if G>4 exchange interaction is negligible. In the 
present case G = 4.62 which shows that the exchange interactions are absent. 
200 2400 2800 3200 
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Figure 11. E.p.r. spectrum of copper complex [C24H28F2N609Cu"l 
Cyclic voltammetry studies 
Since DNA is the primary intracellular target for most of anti-viral and 
anti-bacterial drugs. The exploration of copper complexes as chemical 
nucleases is well documented, because they posses biologically accessible 
redox potential and relatively high nucleo-base affinity [47]. The 
electrochemical behavior of the ligand (L) and its copper complex was studied 
by cyclic voltammetry at different scan rates in the potential range of+ 1.6 to-
1.2V.The cyclic voltammogram of free ligand exhibits a quasireversible redox 
wave with E1/2 = -0.64V and AEp=72mV. The ratio of anodic and cathodic peak 
current (Ipa/Ipc=0.39V) is less than 1 implying quasireversible electron 
transfer. On addition of CTDNA to ligand, both AEp and E1/2 values are shifted 
and peak height decreases remarkably. The shift in formal potential towards 
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more positive direction indicates intercalative mode of binding of ligand with 
CTDNA [48]. 
The cyclic voltammogram of Cu" complex in absence of CTDNA 
exhibits a quasirevesible redox wave for one electron transfer, corresponding to 
Cu'VCu' redox couple with Eia= -0.52V and AEp= 169 mV. The AEp value is 
larger than Nemstian value observed for the one electron transfer couple. The 
ratio of anodic and cathodic peak current (Ipa/Ipc=0.29 V) is less than 1, implying 
quasireversible electron transfer. At different scans rates (0.1-0.3 Vs') , the 
voltammogram do not show any major change in Ep and E|/2 values, clearly 
indicating that Ep is independent of scan rate and Ip is proportional to the V 
[49]. However, at various scan rates the peak height increases indicating the 
reversibility of the process (Figure 2b) On addition of CTDNA to the metal 
complex solution, both AEp and E1/2 values are shifted and peak height decreases 
remarkably (Figure 3a) The ratio of Ipa/Ipc for CTDNA bound metal complex is 
0.24V, which is less than free metal complex. The shift in formal potential (E1/2 
= -0.55V) towards the more negative direction indicates that copper complex 
binds electrostaticaly to the negative charged deoxyribose phosphate back bone 
of CTDNA [50]. 
To elucidate the binding mechanism involving the Cu" and Cu' forms of 
the present complex to CTDNA with the same affinity, the net shift in E1/2 can 
be used to estimate the ratio of equilibrium constant by the following equation. 
Eb*^-Ef''-0.0591 log (K,^2*) 
Cu"+e' ^ Cu' 
K2+ 
Cu"-CTDNA+e" V Cu'-CTDNA 
V 
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On studying the interaction of this complex with CTDNA the ratio of 
binding constant of 1+ and 2+ species was nearly equal to 1.0, suggesting that 
both forms interact with CT-DNA to the same extent [23]. 
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Figure 12. Cyciic voliammogram of complex [C24H28F2N609Cu"j at scan 
rate of 0.1 Vs' in DMSO/H2 O (5:95). 
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Figure 13. CKC//C voltammogram of complex [C24H2«F2N609Cu"l at 
different scane rates (0.1, 0.2, 0.3, VS-') in DMSO/H3O (5:95) 
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Figure 14. Cyclic voliammogram at scan rate 0.2VS^' (a) unbound 
(b) complex in presence ofCTDNA 
Effect of pH on redox behaviour of complex 
Due to the known resemblance between electrochemical and biological 
reactions it can be assumed that the redox mechanism taking place at the 
electrode surface in the given pH and in the body shares similar principles [51]. 
The obtained results from the redox properties of metal based drugs and 
biomolecules might have profound effect on our understanding of their invivo 
redox behaviour or pharmaceutical activity [52]. 
In general, pH is one of the variable that strongly influences the shape of 
voltammograms and thus it is important to investigate the effect of pH on 
electrochemical behaviour of drugs. In this context, the effect of pH on the 
peak current and formal potential (E°) were investigated by cyclic voltammetr} 
in phosphate buffer at different pH's (4,5,7 and 9). The copper complex 
[C24H28F2N6O9CU ], exhibits a well defined quasireversible wave attributed to 
the redox couple Cu'VCu' in the potential range of+1.6 to -1.2V [53]. The 
3] 
formal potential (E") shows a linear variation with pH and is shifted to more 
negative direction with an increase of pH [54]. The height of redox peak was 
found to decrease with increase of pH [Figure 15]. The formal potential reaches 
to a maximum at pH 7, and than decreases abruptly with increasing the pH. It 
was observed that peak height and formal potential was higher in the acidic 
medium than in the basic medium, which is due to instability of copper 
complex in basic medium [55]. 
As it has been reported that the transport of quinlones and their metal 
based derivative across the bacterial cytoplasmic membrane is strongly pH 
dependent and displays maxima at neutral pH [56]. Therefore considering the 
physiological pH (7.4) and sensitivity, voltammetric experiments were carried 
outatpH 7. 
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Interaction of iigand and copper complex with CTDNA 
The binding affinity of Iigand (L) and its Cu" complex have been 
investigated by using absorption spectroscopic titration method of Thorp and 
Bard. Electronic spectra of Iigand exhibited two bands with maximum 
wavelength at 290 nm and 380 nm respectively (Figure 16). On addition of calf 
thymus DNA, there is a slight bathochromic shift of about 4nm and 
hyperchromism of both bands. With the increase of DNA concentration, a 
sharp hypochromism results which clearly indicates intercalative mode of 
binding with CTDNA which may be due to contraction of CTDNA helix as 
well as from the change in the conformation of DNA [57]. On the other hand, 
the electronic spectra of the metal complex revealed two bands at 310 nm and 
400 nm and on addition of CTDNA, there is a large hyperchromism which is 
consistent with electrostatic interaction of copper complex with CTDNA. To 
determine the binding strength of Iigand and [C24H28F2N6O9CU"], the intrinsic 
binding constant (Kb) was measured by monitoring the change in absorbance 
between 250- 400 nm, with increasing concentration of DNA according to 
equation (1) through a plot of [DNA] /eg-Ef versus [DNA] [32]. 
[DNA] = [DNA] + 1 (1) 
Ea-Ef Ea-Ef Kb(Eb-Ef) 
The intrinsic binding constant Kb of Iigand and the copper complex was 
found to be equal to 3.025 x lO" M"' and 2.55 x 10^  M'' respectively. These 
studies clearly indicate that copper based complex has high affinity towards 
CTDNA and can serve as a promising chemotherapeutic agent. 
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Figure 16. (c) Absorption spectral traces of complex [C24H28F2N609Cu"l in 
Tris HCl buffer upon addition of CTDNA. (d) Plot of [DNA]/£„.£/ 
versus [DNA] for the titration of DNA with complex. 
0 0 
-<:t-
0 0 
T f 
O^ 
m 
o 
m 
<N 
m 
O 
m 
r<\ 
O 
m 
O 
r^ 
O 
O 
ro 
i? 
s 
s 
o 
VO 
M-J i n "* 
C I 
•* 
>* 
•^ 
>n 
« 
'3. 
E 
o (J 
B 
T3 
B 
es 
o 
u 
i 
es 
! 
J3 
U 
o 
C. 
o 
I 
J 
O 
00 
u 
c 
*S 
CO 
X 
o 
o w% 
z 
r4 
U 
o O 
VO 
00 
in 
m 
'^ 
00 
*n 
•n 
o 
*—^  
o 
o 
o 
^^  
o 
o 
«n 
o 
•-^  
«n 
i r i 
o 
r^  
^ 
^ 
^1—« 
a> 
>-
00 
c 
? 
o b< 
^ 
.2? 
C 
f > 
o 
CO 
c 
O 
O O 
O 
U 
o 
o 
oo 
X 
U 
o 
z 
oo 
U 
3 
o 
z 
QO 
X 
• ^ 
rg 
u 
t 3 
C/2 
o 
G. £ 
o 
X) 
II 
T3 
o 
X 
I 
> 
n 
o 
z 
f 
> 
o 
> 
• 
> 
u 
I 
> 
o 
H 
u 
o 
08 
u 
(A 
OS 
S 
I 
> 
J* 
£ 
o 
U 
O 
O 
«o 
00 
t 
o 
00 
o 
o 
oo 
o 
00 
o 
m 
00 
I 
o 
CO 
00 
o 
*n r l -
o 
m 
•^r 
t/^ 
«n 
-* 
•>* CO 
Tf 
• > * 
CO 
• ^ 
• < a -
CO 
' f 
^ CO 
^ 
- < 1 -
en 
•^ 
o 
m 
O 
rs 
I 
oo 
CM 
<N 
00 
o 
o 
r-i 
<N 
I 
oo 
<N 
oo 
O 
r-) 
oo 
00 
o 
o 
o 
o 
o 
O 
X 
> 
+ 
o 
o 
•* m 
o 
o 
• * 
r«^ 
O 
O 
'S-
m 
o 
o 
m 
c 
o 
« 
o q:: (^  
CO 
a. 
-a 
c a 
o 
U 
O 
z 
oo 
3 
z 
oc 
U 
z 
o 
z 
U-
oo 
n: 
u 
X 
o o 
u 
V-) 
s 
u 
in 
B o 
I 
00 
E 
d 
a 
ir. 
o 
•o 
B 
o 
•a 
S 
B 
X 
H 
B 
OS 
3 
z 
I 
z 
I 
u 
I 
u 
I 
fs 
m 
<N 
00 
s 
u 
I 
z 
|.i 
X V 
U CI 
z ^ 
X 
I 
00 
en 
o 
00 
I 
C 
00 
E 
d 
•r. 
o 
z 
X 
13 
B 
B 
O 
t. 
cs 
u 
E 
o 
Z 
I 
u 
(N 
o 
o 
I 
U 
o 
lO 
o 
es 
-^ ^ es TS 
L. 
E 
B' 
<J 
f^ 
• • 
^ 
• ^ 
_« 
H 
O II 
u 
o 
o 
u 
1 
o 
VO 
0 0 
1 ^ 
,^-^ 
E 
d. 
• 
Q. ^-^ 
u 
s 
s 
>-
(» 
O 
Q 
B 
^O 
^ 2 *« 
u 
O 
U 
u 
• E 
• 
B 
Q 
«s 
B 
O 
4> 
o u 
•a 
B 
o 
ye 
00 
.St 
E 
o 
u 
o 
t 
s 
X 
E 
22 t- -
(N 
oo 
O 
00 
I 
B 
O 
• * * O 
<» 00 — 
m (N 
OO 
l « 
—^^  
< 
CJ 
c 
!S (U 
o. 
fN 
X U 
1 Z 
f S 
n: u 
1 2 
V 
-o 1 
_c 
'3 
3 
CA 
O 
tn 
c 
o 
o 
1- . o. 
^^-^ 
O 
§ 
o 
_o 
t ^ 
o 
C 
o 
-4—• 
o a. 
u 
00 
'C 
u 
c _'N 
'C 
Q. 
• Q . 
c 
o 
c 
o 
o 
Q. 
£ 
u 
REFERENCES 
38 
References 
[I] T. Khler^ J.C. Pechre. (1998). "Bacterial resistance to quinolones. Mechanism and 
Clinical implications." In : Andriole VT, editor. The quinolones, 2"** ed. New 
York; Academic, pp. 117. 
[2] M.A. Fuertes, C. Alonso and. J.M. Perez, Chem. Rev. 103, 645 (2003). 
[3] L.H. Hurley, Nat. Rev. Cancer. 2,188 (2002). 
[4] B. Macias, M.V. Villia, M.Satre, A.Castineiras and J.Borras. J. Pharmaceutical 
Science, 9,2416 (2002). 
[5] M.S. Singh and K. Tawade, Indian J. Chem., 41B, 419 (2002). 
[6] M. Ruiz, L. S. Perello, J. Carrio, R.G. Ortiz, S. Granda, M.R. Diaz, E. Canton. J. 
Inorg Biochem., 69,231 (1998). 
[7] Li-June Ming. Medicinal Research Review, 23, 697 (2003). 
[8] T. Bando, A. Narita, A. Iwai, K. Kihara and H. Sugiyama, J. Am. Chem. Soc. 126, 
3406 (2004). 
[9] B. Wellenzohn, R.H. Winger, A. Hallbrucker, E. Mayer, K.R. Liedl. J. Am. Chem. 
Soc. 122,3927 (2000). 
[10] S. Narad, N.N. Mishra, P.Pandey, A.Kumar, K.S. Pitre. Indian J. Physiol. 
Pharmacol., 39,166 (1995). 
[II] J.M. Kauffinann and J.C.Vire. Analytica Chimica Acta, 227, 329 (1993). 
[12] Sibel Suzen, B. Tolga Demiricigil, Erdem Buyukbingol and Sibel A.Ozkan, NCM'. 
J. C/iem., 27, 1007(2003) 
[13] S.A. Ozkan, B.Uslu and H.Y. Aboul-Enein, Crit. Rev Anal. Chem., (2003). 
[14] T. Micheal Carter, Marisol Rodriguez, and Allen J. Bard. J. Am. Chem. Soc. 
111,24(1989). 
[15] H. Berg, G. Horn, U. Luthard, W. Inn, Bioelectrochem. Bioenerg., 8, 537 (1981). 
[16] Yang, Gong-Jun. Xu, Jing-Juan. Chen, Hong-Yuan. Leng, Zong-Zhou, Chin. J. 
C;»em., 22,1325 (2004). 
[17] S. Yilmaz, B.UsIu and S.A. Ozkan, Talanta, 54,351 (2001). 
[18] K.L. Goa, H.M. Bryson, A. Markham, Drugs, 53,700 (1997). 
[19] J. Martindale. (1989). "The Extra pharmacopeia", 29'*' ed. The Pharmaceutical 
press, London. 
[20] (a) H.Sigel (1985). "Antibiotics and their complexes", h i : Metal ions in 
biological systems,vol.l9. New York: Marcel Dekker. 
(b) M. Ruyz, L. Perello, J. Server-Carrio, R. Ortiz, S. Garcya-Granda, M.R.Dyaz 
and E .Canton, J. Inorg. Biochem., 69, 231 (1998). 
[21] M.J. Rosemary, V.Suryanarayanan, P.Ganapati Reddy. Ian Maclaren, S. Bakaran 
and T. Pradeep, Proc. Indian Acad. Sci. (Chem Sci.) 115, 703 (2003). 
[22] A. A. Tak, F. Arjmand and S. Tabassum, Transition Met. Chem., 27, 741 (2002). 
[23] X. Lu, K.Zhu, M.Zhang, H. Liu, J. Kang. J. Biochem. Bio. Phys. Methods, 52, 
189(2002). 
[24] M.Zupancic, I. Arcon, P. Bukovec and A. Kodre, Croatica Chemica Acta. 
CCACAA 75 (I), I (2002). 
[25] S. Sortino and G. Condorell, New J. Chem., 26, 250 (2002). 
[26] K. Nakamoto. (1986). "Infrared and Raman Spectra of Inorganic and 
Coordination Compounds", Wiley, New York. 
[27] B. E. Douglas, D. H. McDaniel, J. J. Alexander. (1993). "Concept and Models of 
Inorganic Chemistry" J. Wiley and Sons, Inc., New York. 
[28] R. S. Drago. (1968). "Physical Methods in Inorganic Chemistry," Reinbold 
Publishing Corporation, New York. 
40 
[29] A. J. Bard, and L. R. Eaulkner. (1980). "Electrochemical Methods", Wiley, New 
York, pp. 219. 
[30] K.J. Laidler. (1973). "Chemical Kinetics" Tata Mc Graw Hill Inc., New York. 
[31] A. A. Frost and R. G. Pearson. (1961). "Kinetics and Mechanism", Ed. John 
Wiley and Sons, New York, 11. 
[32] A. Wolfe, G.H. Shimer and T. Mechan, Biochem., 26,6392 (1987). 
[33] J. Murmur, J. Mol. Biol, 3, 208 (1961); 
[34] M. Ereichmann, S.A Rice, C.A Thomes, P. Doty, J. Am. Chem. Soc, 76, 3047 
(1954). 
[35] H-Balundi and A. Chakararvorty. Inorg. Chem., 12, (1981). 
[36] S. Jain, N. K. Jain and K. S. Pitre, Metal-Based Drugs, 9, 1 (2002). 
[37] I. Turel, I. Leban and N. Bukovec, J. Inorg Biochem., 58,273 (1994). 
[38] M.A. Bansarer, M. Gonzalez, M.E. Perez and R.J. Ruano, Polyhed., 5, 1371 
(1986). 
[39] M.S. A.EI-Gaby, M.M.F. Ismail, Y. A. Ammar, M. A. Zauran and N. A.M.M 
Shmieiss. Indian J. Chem., 41B 1480 (2002). 
[40] D.B. Grotjahn, D. Combs and S. Van. Inorg Chetn. 39, 2080 (2000). 
[41] S. Jamees and K.S Nagaraja, Indian J. Chem., 42A 1900 (2003). 
[42] F. Athar, F. Arjmand and S. Tabassum, Transition Met. Chem., 26, 426 (2001). 
[43] J. K. Tang, L. Y. Wang, L. Zhang, E. Q. Gao, D. Z. Liao, Z. H. Jiang, S. P. Yan 
and P. Cheng, J. Chem. Soc, Dalton Trans., 1607 (2002). 
[44] D.W. Ward, CD. Satish, V.H. Kulkami and C. S. Bajgur, Indian J. Chem.. 39A 
415(2000). 
41 
[45] N. Sengottuvelan, D. Saravanakumar, V. Narayanan, M. Kandaswamy, K. 
Chinnakali and G. Senthilkumar, Bull. Chem. Soc. Jpn., 77, 1153 (2004). 
[46] (a) I.M. Proctor, B.J. Hathaway and P. Nicholls, J. Chem. Soc, A, 1678 (1968). 
(b) N.Raman, A. Kulandaisamy and K. Jeyasubramanian. Indian J. Chem., 41 A, 
942 (2002). 
[47] W. K. Pogozelski, T. D. TuUius, Chem. Rev. 98,1089 (1998). 
[48] M.S. Ibrahim, Anal. Chem. Acta, 63,443 (2001). 
[49] B.J. Hathway and A. A.G. Tomlinson, Coord. Chem. Rev., 5, 1 (1970) 
[50] S. Mahadevan and M. Palanian davar, Inorg. Chem., 37,693 (1998). 
[51] "Electroanalytical Techniques in clinical Chemistry and Laboratory Medicine", 
ed. (1998). J. Wang, VCH, New York. 
[52] J.P Hart. (1990). "Electroanalysis of Biologically Important Compounds", Ellis 
Horwood Ltd., England. 
[53] J. Casanova, G. Alzuet, J. Borras and O. Carugo, J. Chem. Soc. Dalton Trans. 
2239(1996). 
[54] Lei Zhang and Xiangqin Lin. Analyst, 126, 367 (2001). 
[55] Z. Goa and Ivaska, Anal. Chim. Acta, 284,393 (1993) 
[56] Y.X. Furet, J. Deshusses, and J.C Pechere, Antimicrob. Agents Chemother. 36, 
2506(1992). 
[57] Q. Li, P. Yang, H. Wang and M. Guo, J. Inorg. Biochem., 64, 181 (1996). 
